Počet záznamov: 1
MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1
- MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1 / C. Gao ... [et al.]. Neoplasma Vol. 61, no. 6 (2014), s. 680-689
článok
Počet záznamov: 1